Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral load and progression.

PI perspective - 1 Mar 1997

Abstract excerpt

Several studies are currently investigating the best ways to use new AIDS drug therapies and handle drug resistance. One study shows that HIV RNA levels in semen strongly correlate with RNA levels in plasma. Other studies report correlations in viral load changes in plasma and lymphoid tissue following combination drug therapy. A study on drug resistance reports that the HIV protease enzyme can develop mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Microbial
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Protease Inhibitors

Share to Lymphoid Tissue

Share to Vagina

Share to Viral Load

Source

Identifiers

PMID: 11364214

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral load and progression.PMID 11364214Read ↗

Viral resistance: how it may affect treatment options.Semantic proximity Read ↗

Effects of drug resistance on viral load in patients failing antiretroviral therapy.Semantic proximity Read ↗

Update on HIV resistance and resistance testing.Semantic proximity Read ↗

Development of anti-retroviral resistance of HIV-1 infected individuals on therapy: is it inevitable?Semantic proximity Read ↗

Development of drug resistance mutations in patients on highly active antiretroviral therapy: does competitive advantage drive evolution.Semantic proximity Read ↗

Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxisSemantic proximity Read ↗

Human immunodeficiency virus drug therapy and virus loadSemantic proximity Read ↗

Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.Semantic proximity Read ↗

Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.Semantic proximity Read ↗

Resistance test welcomed, with caution.Semantic proximity Read ↗

Mathematical approaches in the study of viral kinetics and drug resistance in HIV-1 infection.Semantic proximity Read ↗

Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.